-
Study aim
-
Efficacy evaluation of the Melissa officinalis syrup in treatment of children's anxiety symptoms with ADHD
-
Design
-
Clinical trial with a control group, with parallel groups, double-blind, randomized, phase 3 on 30 patients.
Allocation Concealment method
-
Settings and conduct
-
The subjects of the research will be selected from ADHD sufferers, who referred to the pediatric psychiatric clinic in Ibn Sina Hospital in the second half of 1401. the intervention group will receive the syrup. The amount and safety of the above dose have been shown in previous studies and in the control group, in addition to the standard treatment, placebo syrup with a dose of 10 cc per day in two divided doses will be added to the standard medicine. The same color as herbal syrup is prepared in the same jars. At the beginning of the study and at 3 and 6 weeks, the patients were evaluated with the Attention Deficit Hyperactivity Disorder (ADHD-RS) and Revised Children's Manifest Anxiety Scale (RCMAS). The duration of the intervention in both groups is 6 weeks.
-
Participants/Inclusion and exclusion criteria
-
Patients suffering from ADHD disorder according to DSM V criteria, absence of other systemic and psychiatric disorders, IQ is within the normal range, their age is 7-12 years, and at least three months have passed since their standard drug treatment, and the informed consent form is completed
Exclusion criteria: Patient refusal to continue treatment, occurrence of a systemic disease, initiation of new psychiatric treatment or new onset psychiatric disorder, drug side effects
-
Intervention groups
-
In addition to the standard treatment, the intervention group will be received dose of 0.2 cc per kilogram of weight
The control group will be received a placebo syrup similar to herbal medicine
-
Main outcome variables
-
ADHD-RS scoring questionnaire
The Revised Children's Manifest Anxiety Scale (RCMAS)